High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes

The aims of the present study were to evaluate the expression of prolyl 4-hydroxylase subunit alpha 3 (P4HA3) in adipocytes and adipose tissue and to explore its effect on obesity and type 2 diabetes mellitus (T2DM). We initially demonstrated that P4HA3 was significantly upregulated in the subcutane...

Full description

Bibliographic Details
Main Authors: Langen Zhuang, Can Li, Xiaolei Hu, Qingqing Yang, Xiaoyan Pei, Guoxi Jin
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2022-08-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100652&tlng=en
_version_ 1811215178687053824
author Langen Zhuang
Can Li
Xiaolei Hu
Qingqing Yang
Xiaoyan Pei
Guoxi Jin
author_facet Langen Zhuang
Can Li
Xiaolei Hu
Qingqing Yang
Xiaoyan Pei
Guoxi Jin
author_sort Langen Zhuang
collection DOAJ
description The aims of the present study were to evaluate the expression of prolyl 4-hydroxylase subunit alpha 3 (P4HA3) in adipocytes and adipose tissue and to explore its effect on obesity and type 2 diabetes mellitus (T2DM). We initially demonstrated that P4HA3 was significantly upregulated in the subcutaneous adipose tissue of obesity and T2DM patients, and its functional roles in adipocyte differentiation and insulin resistance were investigated using in vitro and in vivo models. The knockdown of P4HA3 inhibited adipocyte differentiation and improved insulin resistance in 3T3-L1 cells. In C57BL/6J db/db mice fed with a high fat diet (HFD), silencing P4HA3 significantly decreased fasting blood glucose and triglycerides (TG) levels, with concomitant decrease of body weight and adipose tissue weight. Further analysis showed that P4HA3 knockdown was correlated with the augmented IRS-1/PI3K/Akt/FoxO1 signaling pathway in the adipose and hepatic tissues of obese mice, which could improve hepatic glucose homeostasis and steatosis of mice. Together, our study suggested that the dysregulation of P4HA3 may contribute to the development of obesity and T2DM.
first_indexed 2024-04-12T06:17:45Z
format Article
id doaj.art-089873760f244045809df61efbba6aef
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-04-12T06:17:45Z
publishDate 2022-08-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-089873760f244045809df61efbba6aef2022-12-22T03:44:24ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2022-08-015510.1590/1414-431x2022e11741High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetesLangen Zhuanghttps://orcid.org/0000-0003-3700-2715Can Lihttps://orcid.org/0000-0002-9749-5016Xiaolei Huhttps://orcid.org/0000-0001-7536-603XQingqing Yanghttps://orcid.org/0000-0001-6214-3750Xiaoyan Peihttps://orcid.org/0000-0001-5404-8614Guoxi Jinhttps://orcid.org/0000-0001-5944-9142The aims of the present study were to evaluate the expression of prolyl 4-hydroxylase subunit alpha 3 (P4HA3) in adipocytes and adipose tissue and to explore its effect on obesity and type 2 diabetes mellitus (T2DM). We initially demonstrated that P4HA3 was significantly upregulated in the subcutaneous adipose tissue of obesity and T2DM patients, and its functional roles in adipocyte differentiation and insulin resistance were investigated using in vitro and in vivo models. The knockdown of P4HA3 inhibited adipocyte differentiation and improved insulin resistance in 3T3-L1 cells. In C57BL/6J db/db mice fed with a high fat diet (HFD), silencing P4HA3 significantly decreased fasting blood glucose and triglycerides (TG) levels, with concomitant decrease of body weight and adipose tissue weight. Further analysis showed that P4HA3 knockdown was correlated with the augmented IRS-1/PI3K/Akt/FoxO1 signaling pathway in the adipose and hepatic tissues of obese mice, which could improve hepatic glucose homeostasis and steatosis of mice. Together, our study suggested that the dysregulation of P4HA3 may contribute to the development of obesity and T2DM.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100652&tlng=enP4HA3ObesityT2DM
spellingShingle Langen Zhuang
Can Li
Xiaolei Hu
Qingqing Yang
Xiaoyan Pei
Guoxi Jin
High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes
Brazilian Journal of Medical and Biological Research
P4HA3
Obesity
T2DM
title High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes
title_full High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes
title_fullStr High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes
title_full_unstemmed High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes
title_short High expression of P4HA3 in obesity: a potential therapeutic target for type 2 diabetes
title_sort high expression of p4ha3 in obesity a potential therapeutic target for type 2 diabetes
topic P4HA3
Obesity
T2DM
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100652&tlng=en
work_keys_str_mv AT langenzhuang highexpressionofp4ha3inobesityapotentialtherapeutictargetfortype2diabetes
AT canli highexpressionofp4ha3inobesityapotentialtherapeutictargetfortype2diabetes
AT xiaoleihu highexpressionofp4ha3inobesityapotentialtherapeutictargetfortype2diabetes
AT qingqingyang highexpressionofp4ha3inobesityapotentialtherapeutictargetfortype2diabetes
AT xiaoyanpei highexpressionofp4ha3inobesityapotentialtherapeutictargetfortype2diabetes
AT guoxijin highexpressionofp4ha3inobesityapotentialtherapeutictargetfortype2diabetes